Kanayama Kyoko, Ohashi Atsushi, Hasegawa Midori, Kondo Fumiko, Yamamoto Yoshihiro, Sasaki Mayu, Hayashi Hiroki, Kato Masao, Hattori Ryoko, Yamashita Hiroshi, Arai Jiro, Ishii Junichi, Emi Nobuhiko, Yuzawa Yukio
Department of Nephrology, Fujita Health University School of Medicine, Aichi, Japan.
Ther Apher Dial. 2011 Aug;15(4):394-9. doi: 10.1111/j.1744-9987.2011.00964.x.
Renal failure is a frequent complication in patients with multiple myeloma. Immunoglobulin free light chains (FLCs) form casts in the distal tubules, resulting in renal obstruction, and are also directly toxic to proximal renal tubules. Removal of FLCs contributes to renal recovery. High cut-off (HCO) membrane Theralite2100, protein leaking dialyzer PES210Dα, plasma separator Evacure1A20 and β(2) microglobulin adsorption column LixelleS-35 were compared in their FLC removal rate. Dialysis using Theralite2100 or Evacure1A20, diafiltration using PES210Dα and adsorption using LixelleS-35 were performed in an in vitro circuit. The highest removal rate was obtained by Theralite2100 dialysis among the four blood purification methods. Albumin loss was also the greatest in Theralite2100 dialysis. The removal content of FLCs per 1 g albumin loss was better in PES210Dα diafiltration. The removal rate of FLCs by Evacure EC1A-20 dialysis was the third highest. Adsorption of FLCs by the β(2) microglobulin adsorption column Lixelle S-35 was confirmed. In conclusion, Theralite2100 dialysis was the best in removal of FLCs. PES210Dα diafiltration can remove FLCs with smaller loss of albumin.
肾衰竭是多发性骨髓瘤患者常见的并发症。游离免疫球蛋白轻链(FLC)在远端肾小管形成管型,导致肾梗阻,并且对近端肾小管也具有直接毒性。清除FLC有助于肾功能恢复。对高截留量(HCO)膜Theralite2100、蛋白渗漏透析器PES210Dα、血浆分离器Evacure1A20和β2微球蛋白吸附柱LixelleS-35的FLC清除率进行了比较。在体外循环中分别使用Theralite2100或Evacure1A20进行透析、使用PES210Dα进行滤过和使用LixelleS-35进行吸附。在四种血液净化方法中,Theralite2100透析的清除率最高。Theralite2100透析时白蛋白丢失也最大。PES210Dα滤过每丢失1g白蛋白的FLC清除量更佳。Evacure EC1A-20透析的FLC清除率位列第三。证实了β2微球蛋白吸附柱Lixelle S-35对FLC具有吸附作用。总之,Theralite2100透析清除FLC的效果最佳。PES210Dα滤过能够在白蛋白丢失较少的情况下清除FLC。